People News

Share this article:

Marketing research firm IMS Health has announced the election of Bradley Sheares to its board of directors. Shears was most recently CEO of Reliant Pharmaceuticals. Prior to Reliant, Sheares was president of Merck's US human health division.

 

ANI Pharmaceuticals, a specialty generic pharmaceuticals manufacturer, has announced the appointment of Arthur Przbyl as CEO. Przybyl, previously president and CEO of Akorn pharmaceuticals, will also join ANI's board of directors. Przybyl replaces Tom Anderson, ANI's founding CEO, who is leaving to pursue other opportunities.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in People Moves

Email Newsletters

MM&M Future Leaders


Register now

Early bird $1,950 before 31 October 2014

*Group discounts available on request 

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in People Moves

Monday Moves: September 29

Promotions and hires for agencies and manufacturers

Monday Moves—July 21, 2014

Hires and promotions for Manufacturers, Agencies and Media